Pharmaceutics, Vol. 11, Pages 303: Entrapment of N-Hydroxyphthalimide Carbon Dots in Different Topical Gel Formulations: New Composites with Anticancer Activity

Pharmaceutics, Vol. 11, Pages 303: Entrapment of N-Hydroxyphthalimide Carbon Dots in Different Topical Gel Formulations: New Composites with Anticancer Activity Pharmaceutics doi: 10.3390/pharmaceutics11070303 Authors: Corina-Lenuta Savin Crina Tiron Eugen Carasevici Corneliu S. Stan Sorin Alexandru Ibanescu Bogdan C. Simionescu Catalina A. Peptu In the present study, the antitumoral potential of three gel formulations loaded with carbon dots prepared from N-hydroxyphthalimide...

Pharmaceutics

03:00

Pharmaceutics, Vol. 11, Pages 302: Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives

Pharmaceutics, Vol. 11, Pages 302: Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives Pharmaceutics doi: 10.3390/pharmaceutics11070302 Authors: Ketabat Pundir Mohabatpour Lobanova Koutsopoulos Hadjiiski Chen Papagerakis Papagerakis Oral squamous cell carcinoma (OSCC), which encompasses the oral cavity-derived malignancies, is a devastating disease causing substantial morbidity and mortality in both men and...

Pharmaceutics

Sun Jun 30, 2019 03:00

Pharmaceutics, Vol. 11, Pages 301: Hyaluronic Acid-Coated Nanomedicine for Targeted Cancer Therapy

Pharmaceutics, Vol. 11, Pages 301: Hyaluronic Acid-Coated Nanomedicine for Targeted Cancer Therapy Pharmaceutics doi: 10.3390/pharmaceutics11070301 Authors: Kim Choi Choi Park Ryu Hyaluronic acid (HA) has been widely investigated in cancer therapy due to its excellent characteristics. HA, which is a linear anionic polymer, has biocompatibility, biodegradability, non-immunogenicity, non-inflammatory, and non-toxicity properties. Various HA nanomedicines (i.e., micelles,...

Pharmaceutics

Sun Jun 30, 2019 03:00

Mark above section as read